Surrozen (SRZN) Other Non-Current Liabilities (2021 - 2026)

Surrozen (SRZN) recorded quarterly Other Non-Current Liabilities of $148.9 million in Q1 2026, up 32.32% quarter-over-quarter from $112.5 million in Q4 2025, and up 251.04% on a YoY basis from $42.4 million in Q1 2025.

Surrozen (SRZN) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Surrozen's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $148.9 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities rose 251.04% year-over-year to $148.9 million; the TTM figure through Mar 2026 stood at $148.9 million (up 251.04% YoY), while the FY2025 annual figure was $112.5 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was $148.9 million for Q1 2026 at Surrozen, up from $112.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $148.9 million in Q1 2026 to a low of $115000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $29.1 million across 5 years, with a median of $1.6 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities plunged 96.07% in 2022, then jumped 23733.15% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $326000.0 in 2022, then tumbled by 64.72% to $115000.0 in 2023, then surged by 31387.83% to $36.2 million in 2024, then surged by 210.81% to $112.5 million in 2025, then jumped by 32.32% to $148.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $148.9 million (Q1 2026), $112.5 million (Q4 2025), and $53.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Surrozen 225,877.86 -106.68 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 148.92 Mn
Dec 31, 2025 112.55 Mn
Sep 30, 2025 53.54 Mn
Jun 30, 2025 32.62 Mn
Mar 31, 2025 42.42 Mn
Sep 30, 2024 36.21 Mn
Jun 30, 2024 33.03 Mn
Mar 31, 2024 178,000.00
Dec 31, 2023 115,000.00
Sep 30, 2023 243,000.00
Jun 30, 2023 326,000.00
Mar 31, 2023 591,000.00
Dec 31, 2022 326,000.00
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.38 Mn
Mar 31, 2022 1.80 Mn
Dec 31, 2021 8.30 Mn
Sep 30, 2021 8.31 Mn
Jun 30, 2021 5.14 Mn
Mar 31, 2021 2.60 Mn